222 related articles for article (PubMed ID: 6140152)
21. Effect of steroids on drug metabolism in male and female rats.
Stripp B; Menard RH; Zampaglione NG; Hamrick ME; Gillette JR
Drug Metab Dispos; 1973; 1(1):216-23. PubMed ID: 4149385
[No Abstract] [Full Text] [Related]
22. Nuclear drug metabolism: its ontogeny in the rat and its presence in human fetal life.
Romano M; Tursi F; Assael BM; Buscaglia M; Dell'Agnola CA; Salmona M
Prog Clin Biol Res; 1983; 135():395-400. PubMed ID: 6665014
[No Abstract] [Full Text] [Related]
23. Cadmium administration and hepatic drug metabolizing enzyme system: effect of pretreatment with phenobarbital and 3-methyl cholanthrene.
Mgbodile MU
Biochem Int; 1983 Jan; 6(1):11-20. PubMed ID: 6679315
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of renal and liver microsomal cytochrome P-450 system in two animal models.
Yoshimura R; Yoshimura N; Nakatani T; Ohyama A; Miyao Y; Yamamoto K; Kishimoto T
Transplant Proc; 1994 Oct; 26(5):2915. PubMed ID: 7940921
[No Abstract] [Full Text] [Related]
25. Interaction of drugs and nutrition.
Basu TK
J Hum Nutr; 1977 Dec; 31(6):449-58. PubMed ID: 412897
[No Abstract] [Full Text] [Related]
26. Genetic factors in hepatic drug oxidation.
Kalow W; Inaba T
Prog Liver Dis; 1976; 5():246-58. PubMed ID: 775542
[No Abstract] [Full Text] [Related]
27. Hepatic microsomal mixed-function oxidases in rats exposed to high ambient temperature.
Pachecka J; Kobylińska K; Miaskiewicz H; Bicz W
Acta Physiol Pol; 1983; 34(5-6):563-8. PubMed ID: 6679992
[TBL] [Abstract][Full Text] [Related]
28. The effect of ascorbic acid deficiency on extrahepatic microsomal metabolism of drugs and carcinogens in the guinea pig.
Kuenzig W; Tkaczevski V; Kamm JJ; Conney AH; Burns JJ
J Pharmacol Exp Ther; 1977 Jun; 201(3):527-33. PubMed ID: 864591
[No Abstract] [Full Text] [Related]
29. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.
Haaparanta T; Halpert J; Glaumann H; Gustafsson JA
Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054
[TBL] [Abstract][Full Text] [Related]
30. Proceedings: Membrane effect on drug mono-oxygenation activity.
Duppel W; Ullrich V
Hoppe Seylers Z Physiol Chem; 1974 Oct; 355(10):1188. PubMed ID: 4461486
[No Abstract] [Full Text] [Related]
31. Stimulation of microsomal drug oxidation in liver and kidney of rats treated with the oncolytic agent cis-dichlorodiammineplatinum-II.
Litterst CL; Tong S; Hirokata Y; Siddik ZH
Pharmacology; 1983; 26(1):46-53. PubMed ID: 6681909
[TBL] [Abstract][Full Text] [Related]
32. Age and gender effect on the inducibility of steroid metabolizing cytochrome P450 in rat liver.
Lee PC; Struve MF; Werlin SL
Biochem Mol Biol Int; 1994 Nov; 34(5):861-70. PubMed ID: 7703903
[TBL] [Abstract][Full Text] [Related]
33. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
Amato G; Longo V; Mazzaccaro A; Gervasi PG
Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
[TBL] [Abstract][Full Text] [Related]
34. Short-term tests of genotoxicity for 1,1,1-trichloroethane.
Turina MP; Colacci A; Grilli S; Mazzullo M; Prodi G; Lattanzi G
Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):305-20. PubMed ID: 2426748
[TBL] [Abstract][Full Text] [Related]
35. [The role of drug metabolizing enzymes in the effect and side-effect of the drugs].
Vereczkey L; Jemnitz K; Monostory K; Veres Z; Kóbori L
Orv Hetil; 2005 May; 146(19):947-52. PubMed ID: 15969306
[TBL] [Abstract][Full Text] [Related]
36. Metabolism of alpha-naphthylthiourea by rat liver and rat lung microsomes.
Lee PW; Arnau T; Neal RA
Toxicol Appl Pharmacol; 1980 Mar; 53(1):164-73. PubMed ID: 6770492
[No Abstract] [Full Text] [Related]
37. [Microsomal oxidation system in the course of development and aging].
Lemeshko VV
Biokhimiia; 1980 Nov; 45(11):1964-9. PubMed ID: 6786371
[TBL] [Abstract][Full Text] [Related]
38. Covalent binding in vitro of polychlorinated biphenyls to microsomal macromolecules. Involvement of metabolic activation by a cytochrome P-450-linked mono-oxygenase system.
Shimada T; Sato R
Biochem Pharmacol; 1978 Feb; 27(4):585-93. PubMed ID: 204312
[No Abstract] [Full Text] [Related]
39. The skin as a drug-metabolizing organ.
Pannatier A; Jenner P; Testa B; Etter JC
Drug Metab Rev; 1978; 8(2):319-43. PubMed ID: 363387
[No Abstract] [Full Text] [Related]
40. Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites.
Damsten MC; van Vugt-Lussenburg BM; Zeldenthuis T; de Vlieger JS; Commandeur JN; Vermeulen NP
Chem Biol Interact; 2008 Jan; 171(1):96-107. PubMed ID: 17996858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
